This randomized controlled trial evaluated the efficacy of *reclarit*, a cognitive-behavioral digital therapeutic, on psychosocial outcomes in adult rheumatoid arthritis (RA) patients with impaired health-related quality of life. Participants were randomized to *reclarit* plus treatment as usual (TAU) or TAU plus educational materials. *reclarit* significantly improved SF-36 mental component summary (MCS) scores compared to the control group, with sustained improvements at 6 months. Depression, anxiety, fatigue, and social/work functioning also improved significantly. In conclusion, *reclarit* provides effective psychological support for RA patients.
Publisher
npj Mental Health Research
Published On
Sep 03, 2024
Authors
Linda T. Betz, Gitta A. Jacob, Johannes Knitza, Michaela Koehm, Frank Behrens
Tags
rheumatoid arthritis
cognitive-behavioral therapy
digital therapeutic
psychosocial outcomes
health-related quality of life
depression
anxiety
Related Publications
Explore these studies to deepen your understanding of the subject.
